Zenas BioPharma, Inc. (ZBIO)
26.81
+0.70
(+2.68%)
USD |
NASDAQ |
Feb 13, 12:35
Zenas BioPharma EPS Diluted (Quarterly) : -1.222 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.45 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.390 |
| Nektar Therapeutics | -1.875 |
| Rigel Pharmaceuticals, Inc. | 1.456 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.50M |
| Total Expenses (Quarterly) | 51.50M |
| Enterprise Value | 802.20M |
| Earnings Yield | -16.90% |
| Normalized Earnings Yield | -16.59 |